Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Beta-Hydroxy-Beta-methylbutyrate (HMB) and/or 2-hydroxybenzylamine (2-HOBA) on Markers of Health Span in Older Adults. A Randomized Control Trial.

NCT07419633 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT07419633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07419633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Beta-Hydroxy-Beta-methylbutyrate (HMB) and/or 2-hydroxybenzylamine (2-HOBA) on Markers of Health Span in Older Adults. A Randomized Control Trial.
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Not applicable
Overall status
Recruiting
Start date
March 6, 2026
Completion date
February 5, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ageing, ageing and geriatric health, cognitive functioning, geriatric, muscle